These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)]. He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995 [TBL] [Abstract][Full Text] [Related]
3. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST). Du CY; Shi YQ; Zhou Y; Fu H; Zhao G J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605 [TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity. Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270 [TBL] [Abstract][Full Text] [Related]
5. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor. Zheng S; Chen LR; Wang HJ; Chen SZ Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649 [TBL] [Abstract][Full Text] [Related]
6. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis. Arne G; Kristiansson E; Nerman O; Kindblom LG; Ahlman H; Nilsson B; Nilsson O Int J Cancer; 2011 Sep; 129(5):1149-61. PubMed ID: 21064103 [TBL] [Abstract][Full Text] [Related]
7. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated. Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417 [TBL] [Abstract][Full Text] [Related]
8. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size. Rossi S; Gasparotto D; Toffolatti L; Pastrello C; Gallina G; Marzotto A; Sartor C; Barbareschi M; Cantaloni C; Messerini L; Bearzi I; Arrigoni G; Mazzoleni G; Fletcher JA; Casali PG; Talamini R; Maestro R; Dei Tos AP Am J Surg Pathol; 2010 Oct; 34(10):1480-91. PubMed ID: 20861712 [TBL] [Abstract][Full Text] [Related]
9. C-KIT and PDGFRA zygosity in gastrointestinal stromal tumors: Correlation with tumor site, tumor size, exon, and CD117 immunohistochemistry. Wallander ML; Willmore-Payne C; Layfield LJ Appl Immunohistochem Mol Morphol; 2011 Jan; 19(1):21-7. PubMed ID: 20823768 [TBL] [Abstract][Full Text] [Related]
10. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series. Gomes AL; Gouveia A; Capelinha AF; de la Cruz D; Silva P; Reis RM; Pimenta A; Lopes JM J Clin Pathol; 2008 Feb; 61(2):203-8. PubMed ID: 17827398 [TBL] [Abstract][Full Text] [Related]
11. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors. Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309 [TBL] [Abstract][Full Text] [Related]
12. Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors. Jasek K; Buzalkova V; Minarik G; Stanclova A; Szepe P; Plank L; Lasabova Z Virchows Arch; 2017 Jan; 470(1):29-36. PubMed ID: 27864688 [TBL] [Abstract][Full Text] [Related]
13. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors. Sihto H; Sarlomo-Rikala M; Tynninen O; Tanner M; Andersson LC; Franssila K; Nupponen NN; Joensuu H J Clin Oncol; 2005 Jan; 23(1):49-57. PubMed ID: 15545668 [TBL] [Abstract][Full Text] [Related]
14. Strong PDGFRA positivity is seen in GISTs but not in other intra-abdominal mesenchymal tumors: Immunohistochemical and mutational analyses. Peterson MR; Piao Z; Weidner N; Yi ES Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):390-6. PubMed ID: 17122634 [TBL] [Abstract][Full Text] [Related]
15. [Status and clinical analysis of c-kit and PDGFRA mutations in the gastrointestinal stromal tumors]. Du CY; Shi YQ; Zhou Y; Fu H; Zhao GF Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):371-5. PubMed ID: 18636362 [TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor receptor family mutations in gastrointestinal stromal tumours. Sihto H; Franssila K; Tanner M; Vasama-Nolvi C; Sarlomo-Rikala M; Nupponen NN; Joensuu H; Isola J Scand J Gastroenterol; 2006 Jul; 41(7):805-11. PubMed ID: 16785193 [TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases. Miettinen M; Sobin LH; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146 [TBL] [Abstract][Full Text] [Related]
18. Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients. Kang DY; Park CK; Choi JS; Jin SY; Kim HJ; Joo M; Kang MS; Moon WS; Yun KJ; Yu ES; Kang H; Kim KM Am J Surg Pathol; 2007 Feb; 31(2):224-32. PubMed ID: 17255767 [TBL] [Abstract][Full Text] [Related]
19. Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11. Gregory-Bryson E; Bartlett E; Kiupel M; Hayes S; Yuzbasiyan-Gurkan V BMC Cancer; 2010 Oct; 10():559. PubMed ID: 20950418 [TBL] [Abstract][Full Text] [Related]
20. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors. Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]